Local vulnerability and global connectivity jointly shape neurodegenerative disease propagation.


Journal

PLoS biology
ISSN: 1545-7885
Titre abrégé: PLoS Biol
Pays: United States
ID NLM: 101183755

Informations de publication

Date de publication:
11 2019
Historique:
received: 15 07 2019
accepted: 31 10 2019
revised: 05 12 2019
pubmed: 22 11 2019
medline: 15 2 2020
entrez: 22 11 2019
Statut: epublish

Résumé

It is becoming increasingly clear that brain network organization shapes the course and expression of neurodegenerative diseases. Parkinson disease (PD) is marked by progressive spread of atrophy from the midbrain to subcortical structures and, eventually, to the cerebral cortex. Recent discoveries suggest that the neurodegenerative process involves the misfolding and prion-like propagation of endogenous α-synuclein via axonal projections. However, the mechanisms that translate local "synucleinopathy" to large-scale network dysfunction and atrophy remain unknown. Here, we use an agent-based epidemic spreading model to integrate structural connectivity, functional connectivity, and gene expression and to predict sequential volume loss due to neurodegeneration. The dynamic model replicates the spatial and temporal patterning of empirical atrophy in PD and implicates the substantia nigra as the disease epicenter. We reveal a significant role for both connectome topology and geometry in shaping the distribution of atrophy. The model also demonstrates that SNCA and GBA transcription influence α-synuclein concentration and local regional vulnerability. Functional coactivation further amplifies the course set by connectome architecture and gene expression. Altogether, these results support the theory that the progression of PD is a multifactorial process that depends on both cell-to-cell spreading of misfolded proteins and regional vulnerability.

Identifiants

pubmed: 31751329
doi: 10.1371/journal.pbio.3000495
pii: PBIOLOGY-D-19-02034
pmc: PMC6894889
doi:

Substances chimiques

alpha-Synuclein 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e3000495

Subventions

Organisme : CIHR
ID : FDN-143242
Pays : Canada

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Brain. 2015 Sep;138(Pt 9):2648-58
pubmed: 26117366
Science. 2013 Dec 13;342(6164):1337-42
pubmed: 24337289
Nature. 1998 Jun 4;393(6684):440-2
pubmed: 9623998
Science. 2003 Oct 31;302(5646):841
pubmed: 14593171
J Exp Med. 2016 Aug 22;213(9):1759-78
pubmed: 27503075
Cell Tissue Res. 2004 Oct;318(1):121-34
pubmed: 15338272
Nat Rev Neurosci. 2015 Feb;16(2):109-20
pubmed: 25588378
Lancet. 2004 Sep 25-Oct 1;364(9440):1169-71
pubmed: 15451225
Nat Rev Neurosci. 2017 Jan 20;18(2):101-113
pubmed: 28104909
PLoS Comput Biol. 2014 Nov 20;10(11):e1003956
pubmed: 25412207
Science. 2012 Nov 16;338(6109):949-53
pubmed: 23161999
IEEE Trans Med Imaging. 1998 Feb;17(1):87-97
pubmed: 9617910
Science. 2002 May 3;296(5569):910-3
pubmed: 11988575
Elife. 2017 Aug 21;6:
pubmed: 28826495
Neuron. 2012 Mar 22;73(6):1204-15
pubmed: 22445347
Lancet. 2004 Sep 25-Oct 1;364(9440):1167-9
pubmed: 15451224
Brain. 1999 Aug;122 ( Pt 8):1437-48
pubmed: 10430830
Neuron. 2009 Apr 16;62(1):42-52
pubmed: 19376066
Proc Natl Acad Sci U S A. 1998 May 26;95(11):6469-73
pubmed: 9600990
Nature. 2013 Sep 5;501(7465):45-51
pubmed: 24005412
Netw Neurosci. 2019 Mar 01;3(2):475-496
pubmed: 30984903
Nat Rev Neurosci. 2016 Apr;17(4):251-60
pubmed: 26988744
Neurobiol Aging. 2003 Mar-Apr;24(2):197-211
pubmed: 12498954
Phys Rev Lett. 2014 Aug 22;113(8):088701
pubmed: 25192129
Elife. 2015 Sep 07;4:null
pubmed: 26344547
Neuroimage. 2011 Sep 1;58(1):91-9
pubmed: 21704171
J Neurochem. 2013 May;125(4):512-7
pubmed: 23278133
Neuroimage. 2013 Oct 15;80:62-79
pubmed: 23684880
Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11372-7
pubmed: 22711833
Acta Neuropathol. 2018 Jan;135(1):65-83
pubmed: 29209768
Nature. 2012 Sep 20;489(7416):391-399
pubmed: 22996553
Neuroimage. 2016 Jan 1;124(Pt A):379-393
pubmed: 26364864
Neurobiol Aging. 2012 Sep;33(9):2225-8
pubmed: 21813214
Annu Rev Psychol. 2016;67:613-40
pubmed: 26393868
N Engl J Med. 2004 Nov 4;351(19):1972-7
pubmed: 15525722
Neuroinformatics. 2004;2(3):353-60
pubmed: 15365196
Neuroimage. 2012 Aug 15;62(2):782-90
pubmed: 21979382
Proc Natl Acad Sci U S A. 2018 Jun 12;115(24):6297-6302
pubmed: 29848631
Brain Connect. 2011;1(3):169-83
pubmed: 22433046
IEEE Trans Med Imaging. 2010 Sep;29(9):1626-35
pubmed: 20304721
Neuroimage. 2006 Jul 1;31(3):968-80
pubmed: 16530430
Nature. 2015 Jun 18;522(7556):340-4
pubmed: 26061766
Nat Med. 2014 Feb;20(2):130-8
pubmed: 24504409
Neuroimage. 2010 Sep;52(3):1059-69
pubmed: 19819337
Acta Neuropathol. 2018 Jun;135(6):855-875
pubmed: 29502200
Prog Brain Res. 2012;200:221-41
pubmed: 23195421
Cereb Cortex. 2018 Jul 1;28(7):2655-2664
pubmed: 29722805
Nat Rev Neurol. 2013 Jan;9(1):13-24
pubmed: 23183883
Nat Med. 2008 May;14(5):504-6
pubmed: 18391962
Neuroimage. 2014 Jul 1;94:40-46
pubmed: 24650599
Trends Neurosci. 2004 Oct;27(10):607-13
pubmed: 15374672
J Exp Med. 2012 May 7;209(5):889-93
pubmed: 22566400
PLoS One. 2013 Nov 15;8(11):e80713
pubmed: 24348913
Lancet Neurol. 2012 Nov;11(11):986-98
pubmed: 23079555
Brain. 2017 Jul 1;140(7):1959-1976
pubmed: 28549077
J Neurosci Methods. 2012 Jan 30;203(2):386-97
pubmed: 22001222
Prog Neurobiol. 2011 Dec;95(4):629-35
pubmed: 21930184
Neuron. 2002 Jan 31;33(3):341-55
pubmed: 11832223
Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 2000 May;61(5 Pt B):5678-82
pubmed: 11031626
Brain. 2014 Aug;137(Pt 8):2382-95
pubmed: 25057133
Brain. 2013 Apr;136(Pt 4):1128-38
pubmed: 23466394
Phys Rev Lett. 2018 Oct 12;121(15):158101
pubmed: 30362787
J Neurosci. 2017 Oct 11;37(41):9808-9818
pubmed: 29021298
Neuron. 2016 May 18;90(4):675-91
pubmed: 27196972
Neuron. 2011 Oct 6;72(1):57-71
pubmed: 21982369
IEEE Trans Med Imaging. 2008 Apr;27(4):425-41
pubmed: 18390341
Neuron. 2015 Jun 17;86(6):1518-29
pubmed: 26087168
Nat Commun. 2018 Jan 2;9(1):12
pubmed: 29295991
Mov Disord. 2016 Feb;31(2):152-60
pubmed: 26340605

Auteurs

Ying-Qiu Zheng (YQ)

McConnell Brain Imaging Centre, Montréal Neurological Institute, McGill University, Montréal, Quebec, Canada.

Yu Zhang (Y)

McConnell Brain Imaging Centre, Montréal Neurological Institute, McGill University, Montréal, Quebec, Canada.
Centre de Recherche de I'Institut Universitaire de Gériatrie de Montréal, Montréal, Canada.

Yvonne Yau (Y)

McConnell Brain Imaging Centre, Montréal Neurological Institute, McGill University, Montréal, Quebec, Canada.

Yashar Zeighami (Y)

McConnell Brain Imaging Centre, Montréal Neurological Institute, McGill University, Montréal, Quebec, Canada.

Kevin Larcher (K)

McConnell Brain Imaging Centre, Montréal Neurological Institute, McGill University, Montréal, Quebec, Canada.

Bratislav Misic (B)

McConnell Brain Imaging Centre, Montréal Neurological Institute, McGill University, Montréal, Quebec, Canada.

Alain Dagher (A)

McConnell Brain Imaging Centre, Montréal Neurological Institute, McGill University, Montréal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH